TAKEDA PHARMACEUTICAL CO LTD - 24 Jan 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
10%+ Owner
Signature
/s/ Amit Singh, Senior Vice President and Head of Treasury of Takeda Pharmaceutical Company Limited
Issuer symbol
PHAT
Transactions as of
24 Jan 2024
Net transactions value
-$29,999,994
Form type
4
Filing time
25 Jan 2024, 06:13:10 UTC
Previous filing
26 May 2023
Next filing
19 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale $29,999,994 -3,703,703 -50% $8.10 3,755,583 24 Jan 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

TAKEDA PHARMACEUTICAL CO LTD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.